PTGS2 and breast neoplasm: COX-2 is an inflammation cytokine expressed in 40% of invasive breast tumors and has been linked with the increased metastasis and poor prognosis of breast cancer (Miller et al. 2005; Ristimaki et al. 2002; Singh et al. 2007).